Herein, we applied scRNA-seq on paired bone marrow and peripheral blood cells from patients pre- and post-CAR-T therapy targeting BCMA, in the hope of a more detailed description of microenvironment in CAR-T-treated MM. The gene discussed is TNFRSF17; the disease is Miyoshi myopathy.